Startup costs only: CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/23 → 1/31/24

Funding

  • Delfi Diagnostics Incorporated: $4,161.00